Vnitřní lékařství 7/2021

PŘEHLEDOVÉ ČLÁNKY Kardiovaskulární prevence: časná a důsledná prevence versus pozdní intervence, komplexní přístup k léčbě ovlivnitelných rizikových faktorů: hypertenze a dyslipidemie 418 | VNITŘNÍ LÉKAŘSTVÍ / Vnitř Lék 2021; 67(7): 412–418 / www.casopisvnitrnilekarstvi.cz LITERATURA 1. www.czso.cz 2. Zhang Y et al. Associations of Blood Pressre and Choelsterol levels During Young Adul‑ thood With Later Cardiovaskular Events, J Am cool Cardiol 2019 July 23; 74(3): 330–341. 3. Ference et al. Association of Genetic Variants Related to Combined Exposure to Lower Low‑Density Lipoproteins and Lower Systolic Blood Pressure With Lifetime Risk of Car‑ diovascular Disease, JAMA, 2/2019, E 1–11. 4. Mach F, Baigent C, Catapano AL et al. 2019 ESC/EAS Guidelines for the management of dyslipidaemias: lipid modification to reduce cardiovascular risk, European Heart Jour‑ nal (2019) 00, 1–78. 5. SCORE2 working group and ESC Cardiovascular risk collaboration: SCORE2 risk predic‑ tion algorithms: new models to estimate 10-year risk of cardiovascular disease in Europe European Heart Journal, Volume 42, Issue 25, 1 July 2021, Pages 2439–2454. 6. SCORE2-OP working group and ESC Cardiovascular risk collaboration: SCORE2-OP risk prediction algorithms: estimating incident cardiovascular event risk in older per‑ sons in four geographical risk regions. European Heart Journal, Volume 42, Issue 25, 1 July 2021, Pages 2455–2467. 7. Sabatine MS, Giugliano RP, Keech AC, for the FO RIER Steering Committee and Investi‑ gators: Evolocumab and Clincal Ou comes in Patients with Cardiovascular Disease, N Engl J Med 2017; 376:1713–1722. 8. Feron O, Dessy C, Desager JP et al. Hydroxy‑methylglutaryl‑coenzyme A inhibition promotes endothelial nitric oxide synthase activation through a decrease in caveoline abundance. Circulation 2001; 103: 113–118. 9. Jones P, Kafonek S, Laurora I et al. Comparative dose efficacy study of atorvastatin vs. simvastatin, pravastatin, lovastatin and fluvastatin in patients with hypercholesterole‑ mia (The CURVES Study). Am J Cardiol 1998; 81: 582–587. 10. Sever PS, Dahlöf B, Poulter NR, Wedel H, Beevers G, Caulfield M, Collins R, Kjeldsen SE, Kristinsson A, McInnes GT, Mehlsen J, Nieminen M, O‘Brien E, Ostergren J; ASCOT in‑ vestigators. Prevention of coronary and stroke events with atorvastatin in hypertensi‑ ve patients who have average or lower‑than‑average cholesterol concentrations, in the Anglo‑Scandinavian Cardiac Outcomes Trial--Lipid Lowering Arm (ASCOT‑LLA): a multi‑ centre randomised controlled trial. Lancet. 2003 Apr 5; 361(9364): 1149–1158. 11. Gupta A, Mackay J, Whitehouse A et al. ASCOT Legacy study. Lancet 2018; 392: 1127–1137. 12. Widimský J jr, Filipovský J, Ceral F et al. Doporučení pro diagnostiku a léčbu arteriál‑ ní hypertenze ČSH 2017, Hypertenze a kardiovaskulární prevence, Supplementum, 2017. 13. Zlatohlávek L et al. Klinická dietologie a výživa, CurrentMedia, Praha, 2016. 14. McAreavey D, Robertson JIS. Angiotensin converting enzyme inhibitors and mode‑ rate hypertension. Drugs 1990; 40: 326–345. 15. Fox KM. The EURopean Trial On reduction of cardiac events with Perindopril in stable coronary Artery disease Investigators. Efficacy of perindopril in reduction of cardiovascu‑ lar events among patients with stable coronary artery disease: randomised, double‑blind, placebo‑controlled, multicentre trial (the EUROPA study). Lancet 2003; 362: 782–788. 16. Bruining N, deWinter S, Roaelandt JR et al. The Perspective study, Coron Artery Dis 2009, 20: 409–414. 17. Špinar J, Vítovec J. Studie ADVANCE. Remedia 2008; 18: 168–170. 18. van Vark LC, Bertrand M, Akkerhuis KM et al. Angiotensin‑converting enzyme inhi‑ bitors reduce mortality in hypertension: a meta‑analysis of randomized clinical trials of renin‑angiotensin‑aldosterone system inhibitors involving 158,998 patients. Eur Heart J 2012; 33: 2088–2097. 19. Bruno et al. Early and Supernormal VAscular Aging, Hypertension, 2020; 76: 1–9. 09.00 SLEDUJTE NÁS https://www.facebook.com/SolenMedicalEducation/ odemykáme články k aktuálním tématům upozorňujeme na blížící se vzdělávací akce informujeme o nových on-line kurzech s registrací zdarma připravujeme soutěže o vstupenky na kongresy a předplatné časopisů … NA FACEBOOKU AKTUÁLNÍ INFORMACE ze vzdělávání lékařů a lékárníků